Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Remifentanil. An update].

W Wilhelm1, M Wrobel, S Kreuer

  • 1Klinik für Anaesthesiologie und Intensivmedizin, Universitätskliniken des Saarlandes, Homburg/Saar. wolfram.wilhelm@uniklinik-saarland.de

Der Anaesthesist
|July 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-Baseline Search for Active-to-Sterile Neutrino Oscillations in NOvA.

Physical review letters·2025
Same author

Search for CP-Violating Neutrino Nonstandard Interactions with the NOvA Experiment.

Physical review letters·2024
Same author

Relationship among cattle breed and anabolic implant protocol relative to feedlot performance: Growth, temperament, feeding behavior, carcass traits, and economic return.

Domestic animal endocrinology·2023
Same author

Humidity and measurement of volatile propofol using MCC-IMS (EDMON).

Journal of clinical monitoring and computing·2022
Same author

[Erratum to: Treatment of intraoperative hypotension with cafedrine/theodrenaline versus ephedrine. A prospective, national, multicenter, non-interventional study-the HYPOTENS trial].

Der Anaesthesist·2021
Same author

Treatment of intraoperative hypotension with cafedrine/theodrenaline versus ephedrine : A prospective, national, multicenter, non-interventional study-the HYPOTENS trial.

Der Anaesthesist·2020
Same journal

[Promoting young academics in anesthesiology: factors for an attractive internship].

Der Anaesthesist·2022
Same journal

[Respiratory support in COVID-19: all in due time!]

Der Anaesthesist·2022
Same journal

[Noninvasive respiratory support and invasive ventilation in COVID‑19 : Where do we stand today?]

Der Anaesthesist·2022
Same journal

[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].

Der Anaesthesist·2022
Same journal

[Anesthesia in patients with acute porphyria].

Der Anaesthesist·2022
Same journal

[Quality and safe anesthesia for all children : That is their right!]

Der Anaesthesist·2022
See all related articles

Remifentanil, an opioid analgesic, offers rapid intraoperative pain relief and quick postoperative awakening due to its unique metabolism. Its use transforms anesthetic regimens and postoperative pain management strategies.

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Remifentanil is a potent mu-opioid analgesic.
  • It is characterized by rapid metabolism via blood and tissue esterases.
  • This unique pharmacokinetic profile influences anesthetic practices.

Purpose of the Study:

  • To review current knowledge on remifentanil in anesthesiology.
  • To summarize data on remifentanil's use in critically ill patients.
  • To discuss the impact of remifentanil on anesthetic regimens and pain management.

Main Methods:

  • Literature review of remifentanil's pharmacokinetic and pharmacodynamic properties.
  • Analysis of clinical studies comparing remifentanil-based anesthesia with traditional techniques.

Related Experiment Videos

  • Summary of data regarding remifentanil for sedation in intensive care units.

    • Main Results:

    • Remifentanil enables high-dose intraoperative analgesia with rapid, predictable postoperative recovery.
    • Anesthetic regimens, including induction and adjunct choices, are modified by remifentanil use.
    • Postoperative pain management planning is significantly impacted by remifentanil's pharmacokinetic profile.

    Conclusions:

    • Remifentanil represents a significant advancement in anesthetic management.
    • Its use necessitates adjustments in anesthetic techniques and postoperative pain control.
    • Remifentanil is also valuable for analgesia and sedation in critically ill patients.